Our priority is psoriasis, finding remedies for a healthier tomorrow
We make a difference, because we believe there’s an answer to a problem
WHO WE ARE
Discovering first-line treatment for Psoriasis
Alsys mission is deliver a refined and upgraded solution
“Perseverance, patience and commitment of our researchers were three commendable factors, which led us to breakthrough discovery of PRC0028. It is our privilege to help patients with first line treatment for psoriasis.”
OUR TEAM
Dr.rer.nat. Harish Kommera
Bachelor of Pharmacy from Kakatiya, University, India in 2004 and went on to do his post-graduation in Master of Pharmacy, at Martin-Luther-University, Halle (Saale), Germany. Subsequently, In 2010 he received a doctorate from the Department of Pharmacy Biozentrum, Martin-Luther-University, Halle (Saale), Germany. He served as PhD, Research Fellow (New chemical entity screening and qualification) between 2007 to Aug 2010 in the Department of Pharmacology & Medicinal Chemistry- Preclinical Drug Development
Nikhil Chintalapati
Nikhil is a Graduate in Engineering from Vasavi College of Engineering, Hyderabad – 2013 and went on to do his Level 7 Graduation, in WELTEC, New Zealand. He is on the board of Pharma companies Lime Tusker pharma, Cural Herbs and others from 2015
Prof. Dr. Reinhard Paschke
Prof. Dr. Reinhard Paschke is a renowned scientist & Professor in Natural Sciences, University of Halle, Biozentrum, Weinberg, Germany. Dr. Paschke is also heading M/s BioSolutions Halle
GmbH (BSH. BioSolutions Halle GmbH conducts Analysis, active ingredients and natural substances, An expert in microbiological quality control of cosmetics / pharmaceuticals Preservatives stress test Hygiene tests, Preclinical substance research area & evaluation
of the cytotoxic potential of chemical substances on tumour cell lines etc
Dr Biren Sahoo
Dr Biren Sahoo is a postgraduate in medicine who has been working in translational medical research. Dr Sahoo spent two decades in top management positions in global organisations like Terumo Corporation, Japan; Welch Allyn Inc, USA. He has travelled widely and lectured on research methodologies around the world.
Sudheer Karna
M.Sc in Applied Polymer Science from Martin Luther University, Halle, Germany (2009). • B.Pharmacy from Kakatiya University, Warangal, India (2003). Worked as Export consultant in Proinfy Solutions LLC, Georgia, USA from Jan 2016 to July 2017. Worked as Export consultant in AEI CC, Pretoria, South Africa from June 2014 to July 2015. Worked as Director (Marketing) Pharmtech Solutions Pvt. Ltd. Hyderabad, India from July 2010 to May 2014. Worked as Associate Director (Operations) in Glukem Pharmaceuticals Pvt. Ltd. Hyderabad, India from June 2009 to June 2010.
CVR Murthy B.Com, FCA, CS
Murthy, a Fellow Chartered Accountant qualified in 1987 from the Institute of Chartered Accountants of India, . An expert in Structured finance, he has over 28 years of diverse professional consulting experience running beyond the traditional practice areas such as Business modeling, Foreign Investments, Joint ventures, I P O ‘s, M&A etc.
Our History
Alsys Research LLp, is a research-driven pharmaceutical firm, dedicated to discovery of NBEs (new biological entity).
Since 2004, founders are working on a mission to find out an ACTIVE cell for effective psoriasis treatment. Finally, in 2016, they had a breakthrough, identified an extract which proved effective in curing psoriasis.
Our Focus-Psoriasis
We want to help 125 million, i.e. 2 to 3 percent of the total world population suffering from psoriasis, a chronic inflammatory disease.
It is a skin disease, with itchy rash, scaly patches, commonly develops on knees, elbows, trunk and scalp.
An autoimmune disease that affects any age group, has no cure for Pasi Scale 0-7-which has maximum patients.
Alsys PRC0028 compound is the only First Line Treatment for psoriasis at this point of time in the world.